$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Effects of a Selective COX-2 Inhibitor Celecoxib and Soy-Isoflavones on Molecular Markers Related to Apoptosis, and COX-2 and Mapkinase Expression in Estrogen-Fed Rats 원문보기

Nutritional sciences, v.8 no.1, 2005년, pp.16 - 22  

Kim, Tae-Kyung (Department of Food and Nutrition, Hannam University) ,  Park, Ock Jin (Department of Food and Nutrition, Hannam University)

Abstract AI-Helper 아이콘AI-Helper

The present study examined the effects of cyclooxygenase-2 (COX-2) inhibitor celecoxib or soy-isoflavones in the presence of estrogen on apoptosis related gene expression, COX-2 and mapkinase in 48-week old female rats. Expressions of bel-2 and bax proteins, which are known to be involved in the reg...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

가설 설정

  • 37) However, at the higher concentrations, both bcl-2 and bax were up-regulated. Considering that estrogens are potent mitogens in the mammary gland playing a pivotal role in the development and progression of mammary carcinoma, 38) the supplementation of estrogen with soy-isoflavones at the premenopausal state may have more detrimental effect. Tissue differences in the regulation of bcl-2 and bax were clearly shown in this study.
본문요약 정보가 도움이 되었나요?

참고문헌 (47)

  1. Brzozowski AM, Pike CW, Pauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J, Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758, 1997 

  2. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, Hasegawa T, Okada H. Urinary excretion of lignins and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional diet. Am J Clin Nutr 54:1093-1100,1991 

  3. Lee H P, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet 336: 1197-1200, 1991 

  4. Ziegler RG, Hoover RN, Pike MC. Migration patterns and breast cancer risk in Asian-American women. J Nat Cancer Inst 85:1819-1827, 1993 

  5. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 350:990-994,1997 

  6. Zheng W, Dai Q, Custer L, Shu XO, Wen WQ, Jin F, Franke AA. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomark Prev 8:35-40, 1999 

  7. Kroemer G. The proto-oncogene BcI-2 and its role in regulation apoptosis. Nature Med 3:614-620, 1997 

  8. Reed JC BcI-2:Prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9:451-474, 1995 

  9. Xu ZW, Friess H, buchler MW, Solioz M. Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents. Cancer Chemother Pharmacol 49:504-510, 2002 

  10. Li Y, Upadhyay S, Bhuiyan M, Sarkar FH. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18:3166-3172, 1999 

  11. Cao Y, Prescott SM. Many actions of Cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190:279-286, 2002 

  12. Williams CS, Mann M, DuBois RN. The role of cyclo­oxygenases in inflammation, cancer and development. Oncogene 18:7908-7916, 1999 

  13. Trifan OC, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 7:207-222, 2003 

  14. Kismet K, Akay MT, Abbasoglu O, Ercan A. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect Prev 28:127-142, 2004 

  15. Ding H, Han C, Zhu J, Chen CS, D'Ambrosio SM. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9. Int J Cancer 113:803-810, 2005 

  16. Harvell DM, Strecker TE, Tochacek M, Xie B, Pennington KL, McComb RD, Roy SK, Shull JD. Rat strain-specific actions of $17{\beta}$ -estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci, 97:2779-2784, 2000 

  17. Liehr JG, Fang WF, Sirbasku DA, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steriod Biochem 24:353-356, 1986 

  18. Li JJ, Li SA. Estrogen carcinogenesis in hamster tissues: role of metabolism. Fed Proc 46:1858-1863, 1987 

  19. Kohli E, Zalrid M, Rogan E, Cavalieri EL. Greater reactivity of estradiol-3,4-quinone versus estradiol-2,3-quinone with DNA in the formation of depurinating adducts. Proc Am Assoc Cancer Res 44:180, 2003 

  20. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS. A prospective study of endogeous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 67:190-197, 1995 

  21. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer 76:401-405, 1997 

  22. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer risk in post-menopausal women: reanalysis of nine prospective studies. J Natl Cancer lnst 94:606-616,2002 

  23. Thom DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83:2223-2235, 1998 

  24. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 87:897-904, 1996 

  25. Adlercreutz H, Mazur W. Phyto-estrogens and western diseases. Ann Med 29:95-120, 1997 

  26. Shutt DA, Cox I. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J Endocrinol 52:299-310, 1972 

  27. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinol 103:1860-1867, 1978 

  28. Wang TTY, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17:271-275, 1996 

  29. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose­dependent manner. Cancer Res 61:45-50, 2001 

  30. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Fustafsson J, Nilsson S. Differential response of estrogen receptor ${\alpha}$ and estrogen receptor ${\beta}$ to partial estrogen agonists/antagonists. Mole Pharm 54:105-112, 1998 

  31. Breinholt V, Hossaini A, Svendsen G, Brouwer C, Nielsen SE. Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem Toxicol 38:555-564, 2000 

  32. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, Van der Saag PT, Van der Burg B, Gustafsson J. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor ${\beta}$ . Endocrinol 139:4252-4263, 1998 

  33. Routledge EJ, White R, Parker MG, Sumpter JP. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) ${\alpha}$ and $ER{\beta}$ . J BioI Chem 275: 35968-35993, 2000 

  34. Shao A, Alpaugh ML, Fontana JA, Barsky SH. Geinstein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J Cell Biochem 69:44-54, 1998 

  35. Tshilias J, Kapusta L, Slingerland J. The prognostic signi­ficance of altered cyclin-dependent kinase inhibitors in human cancer. Ann Rev Med 50:401-423, 1999 

  36. Constatinou AI, Kamath N, Murley JS. Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur J Cancer 34:1927-1934, 1998 

  37. Leung LK, Wang TT. Bcl-2 is not reduced in the death of MCF-7 cells at low genistein concentration. J Nutr 130:2922-2926, 2000 

  38. Prall OW, Rogan EM, Sutherland RL. Estrogen regulation of cell cycle progression in breast cancer cells. J Steroid Biochem Mol BioI 65:169-174, 1998 

  39. Hla T, Ristimaki A, Appleby S, Barriocanal JG. Cyclooxyg­enase gene expression in inflammation and angiogenesis. Ann N Y Acad Sci 696: 197-204, 1993 

  40. Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson A W. The role of arachidonic acid oxygenation in pain and inflam­mation. Ann Rev lmmunol 2:335-357, 1984 

  41. DuBois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. Cyclooxygenase in biology and diesease. FASEB J 12:1063-1073, 1998 

  42. Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, Boulanger CM. Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin $H_{2}$ in the SHR aorta. Cir Res 76:1003-1010, 1993 

  43. Dyer SM, Taylor DA, Bexis S, Hime NJ, Frewin DB, Head RJ. Identification of a non-endothelial cell thromboxane-like constrictor response and its interaction with the renin-angiotensin system in the aorta of spontaneously hypertensive rats. J Vasc Res 31:5-60, 1994 

  44. Wong E, Huang J, Tagari P, Riendear D. Effects of COX-2 inhibitors on aortic prostacyclin production in cholesterol-fed rabbits. Atherosclerosis 157:393-402, 2001 

  45. Baker CS, Hall RJ, Evans TJ. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc BioI 19:646-655, 1999 

  46. Luscher TF, Aarhus LL, Vanhoutte PM. Indomethacin improves the impaired endothelium-dependent relaxations in small mesenteric arteries of the spontaneously hypertensive rats. Am J Hypertens 3:55-58, 1990 

  47. Ghanam K, Lavagna C, Burgaud J-L, Javellaud J, Ea-Kim L, Oudart N. Involvement of cyclooxygenase 2 in the protective effect of 17 ${\beta}$ -estradiol in hypercholesterolemic rabbit aorta. Biochem Biophy Resear Comm 275:696-703, 2000 

저자의 다른 논문 :

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로